“Sarecycline exhibits decreased activity Against Representative Bacterial and Fungal Microflora Commonly Present in the Human Gastrointestinal Tract”, J of Skin, vol. 5, no. 6, p. s83, Nov. 2021, doi: 10.25251/skin.5.supp.83.